254 related articles for article (PubMed ID: 28404922)
1. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
3. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
5. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
Cao Q; Ruan H; Wang K; Song Z; Bao L; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Liu D; Yang H; Chen K; Zhang X
Int J Oncol; 2018 Jul; 53(1):137-147. PubMed ID: 29749470
[TBL] [Abstract][Full Text] [Related]
7. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
9. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
10. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma.
Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Nakaigawa N; Kishida T; Nagashima Y; Kubota Y
Clin Cancer Res; 2007 Jan; 13(1):152-60. PubMed ID: 17200350
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
Spatz S; Tolkach Y; Jung K; Stephan C; Busch J; Ralla B; Rabien A; Feldmann G; Brossart P; Bundschuh RA; Ahmadzadehfar H; Essler M; Toma M; Müller SC; Ellinger J; Hauser S; Kristiansen G
J Urol; 2018 Feb; 199(2):370-377. PubMed ID: 28827104
[TBL] [Abstract][Full Text] [Related]
15. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
16. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.
Girgis H; Masui O; White NM; Scorilas A; Rotondo F; Seivwright A; Gabril M; Filter ER; Girgis AH; Bjarnason GA; Jewett MA; Evans A; Al-Haddad S; Siu KM; Yousef GM
Mol Cancer; 2014 May; 13():101. PubMed ID: 24885701
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
[TBL] [Abstract][Full Text] [Related]
20. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
